We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGM
3826
DELISTED
Stonegate Mortgage Corporation
SGM
$128K ﹤0.01%
+37,943
New +$175K
HMTV
3827
DELISTED
Hemisphere Media Group, Inc.
HMTV
$126K ﹤0.01%
+10,665
New +$124K
SNAK
3828
DELISTED
Inventure Foods, Inc.
SNAK
$126K ﹤0.01%
+16,069
New +$113K
AIQ
3829
DELISTED
Alliance Healthcare Services
AIQ
$126K ﹤0.01%
+20,321
New +$139K
FENX
3830
DELISTED
Fenix Parts, Inc.
FENX
$126K ﹤0.01%
+32,113
New +$136K
TVRD
3831
Tvardi Therapeutics
TVRD
$22.9M
$125K ﹤0.01%
726
+201
+38% +$43.8K
MTEM
3832
DELISTED
Molecular Templates, Inc.
MTEM
$125K ﹤0.01%
+1,195
New +$85.5K
DL
3833
DELISTED
China Distance Education Holdings Limited
DL
$125K ﹤0.01%
+12,097
New +$151K
GEVO icon
3834
Gevo
GEVO
$363M
$124K ﹤0.01%
526
+274
+109% +$41.4K
SBLK icon
3835
Star Bulk Carriers
SBLK
$3.12B
$124K ﹤0.01%
41,874
+24,188
+137% +$97.2K
CBMG
3836
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$123K ﹤0.01%
+10,311
New +$166K
JIVE
3837
DELISTED
Jive Software, Inc.
JIVE
$121K ﹤0.01%
+32,205
New +$125K
FENG
3838
Phoenix New Media
FENG
$17.5M
$120K ﹤0.01%
+5,432
New +$129K
KRO icon
3839
KRONOS Worldwide
KRO
$712M
$120K ﹤0.01%
+22,843
New +$137K
ROX
3840
DELISTED
Castle Brands, Inc.
ROX
$120K ﹤0.01%
+163,528
New +$140K
CALL
3841
DELISTED
magicJack VocalTec Ltd
CALL
$120K ﹤0.01%
19,090
-13,964
-42% -$85.2K
HIVE
3842
DELISTED
Aerohive Networks
HIVE
$119K ﹤0.01%
18,078
-5,362
-23% -$32.5K
VATE icon
3843
INNOVATE Corp
VATE
$106M
$117K ﹤0.01%
+2,734
New +$110K
VSTM icon
3844
Verastem
VSTM
$547M
$116K ﹤0.01%
+7,412
New +$131K
CACB
3845
DELISTED
Cascade Bancorp
CACB
$115K ﹤0.01%
20,775
+6,718
+48% +$38.3K
TRAK icon
3846
ReposiTrak
TRAK
$159M
$114K ﹤0.01%
+12,768
New +$117K
LCTX icon
3847
Lineage Cell Therapeutics
LCTX
$267M
$112K ﹤0.01%
+49,023
New +$120K
PNNT
3848
Pennant Park Investment Corp
PNNT
$221M
$112K ﹤0.01%
16,444
-72,895
-82% -$472K
TNXP icon
3849
Tonix Pharmaceuticals
TNXP
$158M
0
SB icon
3850
Safe Bulkers
SB
$761M
$111K ﹤0.01%
+105,113
New +$111K

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.